SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Charts for Quick CASH $$$

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Galirayo who wrote (9172)10/20/2000 12:03:26 PM
From: scaram(o)uche  Read Replies (2) of 9262
 
It's not a "big bang" time for the issue. However, it's very much misunderstood.

Equity investment by Wyeth Ayerst was ignored, given the magnitude and what it means in these new days of cash flooding over the sector.

But, it recognized progress in HCV.

Recommend carefully reviewing recent news.... new CEO, HCV, RSV, etc. Then look at the delta between cash in bank and market cap, relative to any other biotech you choose.

So misunderstood that it is justly labeled as a "New Toy".

Again...... biotech capitalizations are spread out in a fashion that holds *NO* relationship to rationale. Position trades have been paying over and over, and conditions now are "best yet" IMO.

Disclaimer...... inherent in this discussion is the fact that "short" position trades, if timed appropriately (fortunately, largely opposite mine), are also doing great.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext